151 results on '"Dacić, Sanja"'
Search Results
2. Artificial Intelligence–Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study
3. Genomic Staging of Multifocal Lung Squamous Cell Carcinomas Is Independent of the Comprehensive Morphologic Assessment
4. The Proposed 9th Edition TNM Classification of Lung Cancer
5. Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer
6. International Association for the Study of Lung Cancer Study of Reproducibility in Assessment of Pathologic Response in Resected Lung Cancers After Neoadjuvant Therapy
7. Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology Committee
8. Characterization of MET Exon 14 Skipping Alterations (in NSCLC) and Identification of Potential Therapeutic Targets Using Whole Transcriptome Sequencing
9. The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015
10. The 2021 WHO Classification of Tumors of the Thymus and Mediastinum: What Is New in Thymic Epithelial, Germ Cell, and Mesenchymal Tumors?
11. Molecular characterization of pleomorphic mesothelioma: a multi-institutional study
12. Solid papillary mesothelial tumor
13. Pleural mesothelioma classification—update and challenges
14. Deep-learning based classification distinguishes sarcomatoid malignant mesotheliomas from benign spindle cell mesothelial proliferations
15. The concept of mesothelioma in situ, with consideration of its potential impact on cytology diagnosis
16. The International Association for the Study of Lung Cancer Global Survey on Programmed Death-Ligand 1 Testing for NSCLC
17. Prognostic Biomarkers in Lung Cancer
18. Translocation Testing of Lung Cancer Biomarkers
19. A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee
20. The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee
21. Comprehensive Molecular and Pathologic Evaluation of Transitional Mesothelioma Assisted by Deep Learning Approach: A Multi-Institutional Study of the International Mesothelioma Panel from the MESOPATH Reference Center
22. IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy
23. PD-L1 Testing for Lung Cancer in 2019: Perspective From the IASLC Pathology Committee
24. Malignant mesothelioma in situ: morphologic features and clinical outcome
25. Interobserver variation in the assessment of the sarcomatoid and transitional components in biphasic mesotheliomas
26. MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma
27. EURACAN/IASLC Proposals for Updating the Histologic Classification of Pleural Mesothelioma: Towards a More Multidisciplinary Approach
28. Best Practices Recommendations for Diagnostic Immunohistochemistry in Lung Cancer
29. Nonspecific Interstitial Pneumonia
30. Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology
31. Interobserver Variation among Pathologists and Refinement of Criteria in Distinguishing Separate Primary Tumors from Intrapulmonary Metastases in Lung
32. THADA fusion is a mechanism of IGF2BP3 activation and IGF1R signaling in thyroid cancer
33. Scientific Advances in Thoracic Oncology 2016
34. Thyroid sclerosing mucoepidermoid carcinoma with eosinophilia: a clinicopathologic and molecular analysis of a distinct entity
35. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases
36. Evaluation of Small Biopsy Material in Patients with Multiple and Secondary Tumors
37. Molecular Targeted Therapy of Lung Cancer
38. Morphological and molecular approach to synchronous non-small cell lung carcinomas: impact on staging
39. The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma
40. Expression of PAM50 Genes in Lung Cancer: Evidence that Interactions between Hormone Receptors and HER2/HER3 Contribute to Poor Outcome
41. Accuracy of the IASLC/ATS/ERS histological subtyping of stage I lung adenocarcinoma on intraoperative frozen sections
42. Adjuvant Osimertinib vs. Placebo in Completely Resected Stage IA2–IA3 EGFR-Mutated NSCLC: ADAURA2
43. Molecular Prognostic Markers of Lung Cancer
44. Neuroendocrine Lung Tumors
45. Reproducibility of Histopathological Diagnosis in Poorly Differentiated NSCLC: An International Multiobserver Study
46. KRAS mutational analysis and immunohistochemical studies can help distinguish pancreatic metastases from primary lung adenocarcinomas
47. Applications in Anatomic Pathology
48. Identification of the transforming STRN-ALK fusion as a potential therapeutic target in the aggressive forms of thyroid cancer
49. Applications of Molecular Tests in Anatomic Pathology
50. Tiazofurin modulates lipopolysaccharide-activated microglia in vitro
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.